Philadelphia, May 10, 2022 – Using an artificial intelligence (AI) tool that emulates how humans visualize and is trained to recognize and classify images, investigators constructed a model that predicts the postoperative recurrence of Crohn disease with high accuracy by evaluating histological images. The AI tool also revealed previously unrecognized differences in adipose cells and significant differences in the extent of mast cell infiltration in the subserosa, or outer lining of the intestine, comparing patients with and without disease recurrence. The findings appear in The American Journal of Pathology, published by Elsevier.
Trending
- Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening (Business Wire)
- AI Tool Identifies Undiagnosed Early-Stage MASLD (MDedge)
- Joining forces to develop a multidisciplinary care model in GI (Takeda)
- Zepbound sheds more weight than Wegovy in trial, Eli Lilly says (NBC News)
- Cheap, non-invasive tool that detects bowel disease coming in 2027: Hong Kong scientists (South China Morning Post)
- Some Older Adults Think Stopping CRC Screening at Age 75 Is ‘Unacceptable’ (MedPage Today)
- Why Operators Are Embracing Hybrid ASC, Office-Based Lab Models (ASC News)
- This year, be thankful for AI in medicine (The Washington Post)